Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
Phase 3
Completed
- Conditions
- First Posted Date
- 2004-05-05
- Last Posted Date
- 2006-11-01
- Lead Sponsor
- Kos Pharmaceuticals
- Registration Number
- NCT00082251
Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)
Phase 3
Completed
- Conditions
- First Posted Date
- 2004-03-29
- Last Posted Date
- 2006-11-01
- Lead Sponsor
- Kos Pharmaceuticals
- Target Recruit Count
- 600
- Registration Number
- NCT00080275
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Phase 4
Completed
- Conditions
- First Posted Date
- 2004-03-12
- Last Posted Date
- 2006-11-01
- Lead Sponsor
- Kos Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT00079638
The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-10-20
- Last Posted Date
- 2006-11-02
- Lead Sponsor
- Kos Pharmaceuticals
- Target Recruit Count
- 870
- Registration Number
- NCT00071266
- Locations
- 🇺🇸
Penn State College of Medicine, Hershey, Pennsylvania, United States
🇺🇸North County Internal Medicine, Vista, California, United States
🇺🇸Care Foundation, Inc, Wausau, Wisconsin, United States
Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
Phase 3
Completed
- Conditions
- First Posted Date
- 2003-06-12
- Last Posted Date
- 2006-11-01
- Lead Sponsor
- Kos Pharmaceuticals
- Target Recruit Count
- 366
- Registration Number
- NCT00062556
© Copyright 2024. All Rights Reserved by MedPath